EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Efficacy and safety of biologic therapies in immune checkpoint inhibitor‐induced bullous pemphigoid

Ghassan Barnawi iD, Ruba Alghanmi, Camelia Amara, Raquel Lazarowitz iD, Elen Grigorchuk, Houriah Nukaly iD, Ivan V Litvinov

Journal of the European Academy of Dermatology and Venereology · 2026-08 · 40 (8)

DOI: 10.1111/jdv.70413 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 18.03.2026. Verfasst von Ghassan Barnawi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, McGill University, Montreal, Quebec, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bullous pemphigoiddupilumabimmune checkpoint inhibitoromalizumabrituximab

Autor:innen und Institutionen

  • Division of Dermatology, McGill University, Montreal, Quebec, Canada.
  • College of Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada.
  • Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada.
  • Department of Specialized Medicine (Dermatology), St. Mary's Hospital Centre, Montreal, Quebec, Canada.

ORCID-Profile: Ghassan Barnawi, Raquel Lazarowitz, Houriah Nukaly

Zitieren

APA

Barnawi, G., Alghanmi, R., Amara, C., Lazarowitz, R., Grigorchuk, E., Nukaly, H., & Litvinov, I. V. (2026). Efficacy and safety of biologic therapies in immune checkpoint inhibitor‐induced bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology, 40(8). https://doi.org/10.1111/jdv.70413

Vancouver

Barnawi G, Alghanmi R, Amara C, Lazarowitz R, Grigorchuk E, Nukaly H, et al. Efficacy and safety of biologic therapies in immune checkpoint inhibitor‐induced bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. 2026;40(8). doi:10.1111/jdv.70413

BibTeX
@article{Barnawi2026,
  author = {Barnawi, Ghassan and Alghanmi, Ruba and Amara, Camelia and Lazarowitz, Raquel and Grigorchuk, Elen and Nukaly, Houriah and Litvinov, Ivan V},
  title = {Efficacy and safety of biologic therapies in immune checkpoint inhibitor‐induced bullous pemphigoid},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  volume = {40},
  number = {8},
  doi = {10.1111/jdv.70413}
}
Kostenlos starten →